Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Adverum Biotechnologies, Inc. | advm-ex321_144.htm |
| EX-31.2 - EX-31.2 - Adverum Biotechnologies, Inc. | advm-ex312_143.htm |
| EX-31.1 - EX-31.1 - Adverum Biotechnologies, Inc. | advm-ex311_142.htm |
| EX-21.1 - EX-21.1 - Adverum Biotechnologies, Inc. | advm-ex211_145.htm |
| EX-10.40 - EX-10.40 - Adverum Biotechnologies, Inc. | advm-ex1040_748.htm |
| EX-10.39 - EX-10.39 - Adverum Biotechnologies, Inc. | advm-ex1039_747.htm |
| EX-3.1 - EX-3.1 - Adverum Biotechnologies, Inc. | advm-ex31_910.htm |
| 10-K - ADVM-10K-20161231 - Adverum Biotechnologies, Inc. | advm-10k_20161231.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statements No. 333-199296, No. 333-203398, and No. 333-211439 on Form S-8 of our report dated March 8, 2017, relating to the consolidated financial statements of Adverum Biotechnologies, Inc. and its subsidiaries appearing in this Annual Report on Form 10-K of Adverum Biotechnologies, Inc. for the year ended December 31, 2016.
/s/ DELOITTE & TOUCHE LLP
San Jose, California
March 8, 2017